| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |